Blocking an N-terminal acetylation–dependent protein interaction inhibits an E3 ligase
2017 · Nature Chemical Biology · 110 citations
https://doi.org/10.1038/nchembio.2386
J
Jonathan Low
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
75
Papers
2.3K
Citations
23
h-index
33
i10-index
Jonathan Low is an academic researcher from St. Jude Children's Research Hospital. The author has contributed to research in topics: Protein Degradation and Inhibitors & Neuroblastoma Research and Treatments & Epigenetics and DNA Methylation. The author has an h-index of 23, co-authored 64 publications.
Papers by this author
worksA CRISPR-drug perturbational map for identifying compounds to combine with commonly used chemotherapeutics
2023 · Nature Communications · 20 citations
https://doi.org/10.1038/s41467-023-43134-0
Bone morphogenetic protein (BMP) signaling determines neuroblastoma cell fate and sensitivity to retinoic acid
2025 · Nature Communications · 3 citations
https://doi.org/10.1038/s41467-025-57185-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat